Mirae Asset Global Investments Co. Ltd. Boosts Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Mirae Asset Global Investments Co. Ltd. increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 3.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 531,003 shares of the company's stock after purchasing an additional 15,671 shares during the quarter. Mirae Asset Global Investments Co. Ltd. owned 0.12% of GE HealthCare Technologies worth $41,057,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Armstrong Henry H Associates Inc. raised its position in GE HealthCare Technologies by 3.9% in the third quarter. Armstrong Henry H Associates Inc. now owns 4,105 shares of the company's stock worth $279,000 after acquiring an additional 153 shares during the period. Chicago Capital LLC raised its position in GE HealthCare Technologies by 2.8% in the third quarter. Chicago Capital LLC now owns 6,081 shares of the company's stock worth $414,000 after acquiring an additional 163 shares during the period. Chilton Capital Management LLC raised its position in GE HealthCare Technologies by 15.4% in the fourth quarter. Chilton Capital Management LLC now owns 1,227 shares of the company's stock worth $95,000 after acquiring an additional 164 shares during the period. Procyon Advisors LLC raised its position in GE HealthCare Technologies by 5.2% in the fourth quarter. Procyon Advisors LLC now owns 3,555 shares of the company's stock worth $275,000 after acquiring an additional 175 shares during the period. Finally, Forum Financial Management LP raised its position in GE HealthCare Technologies by 3.9% in the third quarter. Forum Financial Management LP now owns 4,989 shares of the company's stock worth $339,000 after acquiring an additional 186 shares during the period. Hedge funds and other institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Price Performance

NASDAQ GEHC traded up $0.51 on Friday, reaching $88.47. The company had a trading volume of 1,574,849 shares, compared to its average volume of 3,676,913. The company has a quick ratio of 0.83, a current ratio of 1.05 and a debt-to-equity ratio of 1.18. The stock has a market capitalization of $40.29 billion, a PE ratio of 29.29, a price-to-earnings-growth ratio of 3.08 and a beta of 0.94. The firm's 50 day moving average price is $86.92 and its 200 day moving average price is $76.61. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.07 by $0.11. The company had revenue of $5.20 billion for the quarter, compared to the consensus estimate of $5.09 billion. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. GE HealthCare Technologies's revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.31 EPS. As a group, equities analysts predict that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be issued a $0.03 dividend. The ex-dividend date is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 3.97%.

Analysts Set New Price Targets

Several research firms have weighed in on GEHC. Mizuho increased their price target on shares of GE HealthCare Technologies from $94.00 to $96.00 and gave the stock a "buy" rating in a research report on Wednesday, February 7th. Evercore ISI raised their price objective on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an "outperform" rating in a research report on Thursday. Morgan Stanley raised their price objective on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an "equal weight" rating in a research report on Monday, February 12th. UBS Group upgraded shares of GE HealthCare Technologies from a "sell" rating to a "neutral" rating and raised their price objective for the company from $66.00 to $88.00 in a research report on Monday, February 12th. Finally, Argus raised their price objective on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a "buy" rating in a research report on Monday, April 1st. Five research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, GE HealthCare Technologies currently has an average rating of "Moderate Buy" and an average target price of $93.92.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.